Daiichi Sankyo Loses Patent Term Adjustment Challenge
The Federal Circuit on Thursday rejected a pharmaceutical company's challenge to the way the U.S. Patent and Trademark Office calculated patent term adjustments for two of its patents on treating dead...To view the full article, register now.
Already a subscriber? Click here to view full article